Status:

RECRUITING

A Portable Thoracic Impedance Device for Detecting Pulmonary Congestion in Heart Failure Patients

Lead Sponsor:

Centre hospitalier de l'Université de Montréal (CHUM)

Conditions:

Heart Failure

Eligibility:

All Genders

18+ years

Brief Summary

This study investigates a portable thoracic bioimpedance tomography (TBIT) device designed to detect early lung congestion in heart failure patients. The main goal is to evaluate how well the device's...

Detailed Description

The primary objective is to determine the correlation between TBIT measurements and B-line scores obtained via portable lung ultrasound, with secondary objectives including correlations with thoracic ...

Eligibility Criteria

Inclusion

  • Adults aged 18 years or older.
  • Diagnosed with heart failure, defined by the following criterion: hospitalization or an emergency visit for decompensated heart failure (pulmonary edema) within the last 12 months.

Exclusion

  • Pregnant women at the time of eligibility evaluation.
  • Presence of an implanted electronic device in the thorax, such as a pacemaker or defibrillator.
  • Inability to provide informed consent.
  • Admission to intensive care or the coronary care unit.

Key Trial Info

Start Date :

September 1 2025

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

September 1 2026

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT06604468

Start Date

September 1 2025

End Date

September 1 2026

Last Update

October 6 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

CHUM

Montreal, Quebec, Canada, H2X 3H8

A Portable Thoracic Impedance Device for Detecting Pulmonary Congestion in Heart Failure Patients | DecenTrialz